The Hetero Ring Shares The 5,6-positions Of The Cyclopentanohydrophenanthrene Ring System Patents (Class 540/80)
  • Patent number: 8598339
    Abstract: The present invention features novel withanolides, as well as analogs and salts thereof, for use in the treatment of proliferative disease, cardiovascular disease, neurodegenerative disease and inflammatory disease.
    Type: Grant
    Filed: February 1, 2012
    Date of Patent: December 3, 2013
    Assignee: University of Kansas
    Inventors: Barbara N. Timmermann, Jeffrey Aube, Huaping Zhang, Rao Gollapudi, Mark S. Cohen, Abbas Samadi, Hashim Fakhsuddin-Motiwala
  • Publication number: 20130115316
    Abstract: A group of indolealkylamino-withasteroid conjugates, isolated and purified from Withania somnifera, are described. A synthetic method of making an indolealkylamino-withasteroid compound is provided. In vitro acetyl cholinesterase inhibitory activity and methods for treatment of dementia and dementia-related disorders, such as Alzheimer's disease, and anxiety and depressive disorders in mammals are demonstrated with these novel compositions.
    Type: Application
    Filed: November 5, 2012
    Publication date: May 9, 2013
    Applicant: NATREON, INC.
    Inventor: Natreon, Inc.
  • Publication number: 20120196815
    Abstract: The present invention features novel withanolides, as well as analogs and salts thereof, for use in the treatment of proliferative disease, cardiovascular disease, neurodegenerative disease and inflammatory disease.
    Type: Application
    Filed: February 1, 2012
    Publication date: August 2, 2012
    Applicant: Kansas University Center for Technology Commercialization
    Inventors: Barbara N. Timmermann, Jeffrey Aube, Huaping Zhang, Rao Gollapudi, Mark S. Cohen, Abbas Samadi, Hashim Fakhruddin-Motiwala
  • Publication number: 20100324003
    Abstract: New aminooxime derivatives at position 3 of 2- and/or 4-substituted androstanes and androstenes, processes for their preparation, and to pharmaceutical compositions containing them for the treatment of cardiovascular disorders, such as heart failure and hypertension. In particular compounds having the general formula (I) are described, where the radicals have the meanings described in detail in the application.
    Type: Application
    Filed: September 18, 2008
    Publication date: December 23, 2010
    Applicant: SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A.
    Inventors: Alberto Cerri, Giuseppe Bianchi, Giorgio Fedrizzi, Patrizia Ferrari, Mauro Gobbini, Giuseppe Marazzi, Marco Torri, Walter Cabri
  • Publication number: 20080207574
    Abstract: Novel withanolide chemical genetic probes identify the in vivo binding target of withaferin A, which is the intermediate filament type III protein vimentin. In addition, a withanolide-based small molecule screening method screens drug candidates that target intermediate filament type III proteins. The method includes introducing a tagged linker covalently bonded to the withanolide molecule to form a withanolide probe. Better or alternative small molecule compounds as potential drug candidates can be generated based on their likely affinity for the determined binding site in vimentin. The affinity labeled withanolide can also be used to find intermediate filament-associated proteins using chemical proteomics by extracting proteins from cells that were exposed to withanolide-biotin analog. The withanolide probes can be used to monitor expression of vimentin, in tumor samples or other diseased tissues.
    Type: Application
    Filed: February 14, 2007
    Publication date: August 28, 2008
    Inventors: Royce Mohan, Paola Bargagna-Mohan, Kyung Bo Kim
  • Patent number: 6841665
    Abstract: A general, efficient, and environmentally friendly method is provided for producing mostly ?-epoxides of ?5-unsaturated steroids using certain ketones as the catalyst along with an oxidizing agent, or by using certain dioxiranes. In another aspect of the invention, a method is provided for producing mostly 5?,6?-epoxides of steroids from ?5-unsaturated steroids having a substituent at the 3?-position by an epoxidation reaction using a ketone along with an oxidizing agent under conditions effective to generate epoxides, or using a dioxirane under conditions effective to generate epoxides. A whole range of ?5-unsaturated steroids, bearing different functional groups such as hydroxy, carbonyl, acetyl or ketal group as well as different side chains, were conveniently converted to the corresponding synthetically and biologically interesting 5?,6?-epoxides with excellent ?-selectivities and high yields.
    Type: Grant
    Filed: March 6, 2002
    Date of Patent: January 11, 2005
    Assignee: The University of Hong Kong
    Inventors: Dan Yang, Guan-Sheng Jiao
  • Publication number: 20030018188
    Abstract: A general, efficient, and environmentally friendly method is provided for producing mostly &bgr;-epoxides of &Dgr;5-unsaturated steroids using certain ketones as the catalyst along with an oxidizing agent, or by using certain dioxiranes. In another aspect of the invention, a method is provided for producing mostly 5&bgr;,6&bgr;-epoxides of steroids from &Dgr;5-unsaturated steroids having a substituent at the 3&agr;-position by an epoxidation reaction using a ketone along with an oxidizing agent under conditions effective to generate epoxides, or using a dioxirane under conditions effective to generate epoxides. A whole range of &Dgr;5-unsaturated steroids, bearing different functional groups such as hydroxy, carbonyl, acetyl or ketal group as well as different side chains, were conveniently converted to the corresponding synthetically and biologically interesting 5&bgr;,6&bgr;-epoxides with excellent &bgr;-selectivities and high yields.
    Type: Application
    Filed: March 6, 2002
    Publication date: January 23, 2003
    Inventors: Dan Yang, Guan-Sheng Jiao
  • Patent number: 5681950
    Abstract: Withajardins A-D are new class of withanolides isolated from the leaves of Deprea orinocensis and characterized by having a bicyclic C-17.beta. system and hydroxyl group at C-14 and C-17. The bicyclic system consists of a lactone and a homocyclic ring with six carbon atoms unlike the acnistins which have a five-membered homocyclic ring. The two classes of compounds were differentiated and their structures were identified by a series of HMQC, HMBC and finally X-ray diffraction experiments. Withajardins and acnistins would seem to evolve along quite dissimilar biosynthetic pathways although both types of compound show a marked immunosupressive effect on in vitro cultures of human lymphocytes.
    Type: Grant
    Filed: September 28, 1994
    Date of Patent: October 28, 1997
    Assignees: Universidad De Antioquia, Colciencias
    Inventors: Luis F. Echeverri-Lopez, Luis F. Torres-Roldan, Luis F. Garcia-Moreno, Gloria Cardona-Rendon, Winston Quinones-Fletcher, Javier Gutierrez-Luis, Antonio Gonzalez-Gonzalez, Carlos A. Pelaez-Jaramillo, Mauricio Rojas-Lopez